SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

INOs FDA approval is prompting traders to speculate that the agency may be more receptive to rare-disease treatments, lifting attention on Capricor ahead of deramiocels FDA decision for Duchenne muscular dystrophy. The community is divided: some see the approval, recent data and launch-related hiring as encouraging signals, while others stress that CAPRs outcome is uncertain given prior FDA concerns and debate over the evidence.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

SMH is under pressure in a sharp semiconductor selloff as traders question whether heavy AI infrastructure spending will deliver sufficient returns, with weak Intel guidance and Amazons elevated capital spending adding to tech-sector jitters. The community is divided between warnings that AI-related investment and financing risks could prolong the decline and dip buyers pointing to strong demand and oversold conditions.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of a competing treatment for recurrent respiratory papillomatosis has put Precigens PAPZIMEOS in focus, prompting debate over the threat of new competition. Some traders worry about market share, while others argue Precigens first-mover advantage, commercial launch, and full approval temper the risk compared with Inovios accelerated approval.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A stronger-than-expected quarterly report, fueled by demand for Mounjaro and Zepbound and a higher full-year revenue outlook, is driving LLYs rally and analyst upgrades. Bullish traders point to continued obesity-drug growth, while skeptics flag the trimmed profit outlook and high valuation.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could decline significantly during 2027 has fueled a sharp selloff, raising concerns about pricing and CorMedixs largest revenue driver. Traders disagree over whether DaVitas preliminary outlook signals lasting pressure, pointing to CMSs more reassuring payment estimate and arguing the reaction may be excessive.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons stronger-than-expected third-quarter results, supported by growth in Eylea HD and Sanofi collaboration sales from Dupixent, are driving attention. Traders are broadly bullish on the sharp rally and breakout, while some are weighing whether the gains can be sustained.

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

MercadoLibre is drawing attention after a sharp selloff tied to Brazils election results and broader weakness in Brazilian-linked stocks. Traders disagree over whether political and market risks signal further downside or create a buying opportunity, with some pointing to the companys continued growth ahead of earnings.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZenecas stronger-than-expected quarterly results and cost-savings plan to support drug development are driving attention, alongside CEO optimism about its pipeline. Traders are reacting to the sharp rise and move above the 200-day average with broadly bullish commentary.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Robloxs quarterly results beat estimates, but declining user activity and a forecast for lower fourth-quarter bookings have driven a sharp selloff. Traders are largely bearish over slowing growth and monetization, while some view the drop as an overreaction and a buying opportunity.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas earnings beat and raised outlook, alongside its positioning as an identity-security layer for AI agents, have fueled a sharp cybersecurity-led rally. Traders are divided over whether demand can justify the valuation, with some taking profits or betting on a pullback after the run-up.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Micron Technology Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

Shares of Micron Technology Inc (NASDAQ: MU) surged in pre-market trading after reporting strong Q3 results and issuing strong guidance. Autozi Internet Technology, Focus Universal, SAGTEC GLOBAL, Eshallgo, Eco Wave Power Global, Innovation Beverage Group, Nexera Technologies, Methode Electronics...

IBG Stock Surges 70% Pre-Market Today: Retail Eyes Its ‘Nano Float’ And Upcoming BlockFuel Energy Merger

Equity

IBG and BlockFuel Energy, whose merger was announced in October, expect to finalize their combination during the first quarter of 2026.


Carvana, Tapestry & Dollar Stores Emerge As Top Consumer Gainers In 2025, But Retail Trader Eyes Are Firmly On Riskier Bets

Consumer stocks that saw the largest jump in followers on Stocktwits are down sharply year-to-date, underscoring retail traders’ appetite for volatility over fundamentals.

Innovation Beverage Stock Falls 10% Premarket, Losing Momentum From Merger With Bitcoin Mining Power Supplier

On Wednesday, the Australian beverages company announced a reverse triangular merger with Texas-based BlockFuel Energy.

Innovation Beverage Soars On Potential Merger With BlockFuel Energy – Here’s An Important Development On Reverse Stock Split

The post-transaction combined company resulting from the merger is expected to have an equity valuation range of approximately $220 million to $343 million.

10 Stocks/Cryptos With Biggest Increases In Followers On Stocktwits Last Week

Dogecoin, SPY, Bitcoin, Ripple and Innovation Beverage were among the securities that drew retail attention last week.

Innovation Beverage Group (NASDAQ: IBG) Partners Nationwide with Sysco (NYSE:SYY) – Potential for Significant Revenue Growth in $4.4 Billion US market 

public companies

Innovation Beverage Group partners with Sysco to distribute Australian Bitters across the U.S., tapping into 40% of the $11B bitters market and positioning itself for significant revenue growth in the expanding foodservice sector.


Innovation Beverage Group Ltd. engages in developing, manufacturing, marketing, exporting, and retailing alcoholic and non-alcoholic brands. It operates through the following geographical segments: Australia and United States. The company was founded by Meena Beri, Amit Beri and Sahil Beri on April 20, 2018 and is headquartered in Seven Hills, Australia.

Innovation Beverage Group Ltd

Bullish Sentiment

Innovation Beverage Group (IBG) stock is drawing retail interest on Friday ahead of its pending merger with BlockFuel Energy Inc., an oil and gas exploration company that supplies power to Bitcoin mining operations.The company’s tiny public float of 559,640 shares has caught investors’ attention due to its potential for ‘meme stock’ like explosive gains.&nbsp;<h2 class="st-heading-2">What Are Stocktwits Users Saying?&nbsp;</h2><a href="https://stocktwits.com/symbol/IBG">Innovation Beverage stock</a> traded 70% higher in Friday’s premarket and is on track to hit its January 2026 high. On Stocktwits, retail sentiment around the stock jumped to ‘bullish’ from ‘neutral’ territory the previous day. Message volume flipped to ‘high’ from ‘low’ levels in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_06_054430_png_12f9d4ccb8.webp" alt="IBG’s Sentiment Meter and Message Volume as of 05:45 a.m. ET on Mar. 6, 2026 | Source: Stocktwits" width="928" height="94"><figcaption>IBG’s Sentiment Meter and Message Volume as of 05:45 a.m. ET on Mar. 6, 2026 | Source: Stocktwits</figcaption></figure>Bullish Stocktwits users sounded excited about the company’s ‘nano float’ of shares.&nbsp;<stembedurl>https://stocktwits.com/BTC_Will_Hit_14K/message/646771238</stembedurl><stembedurl>https://stocktwits.com/JordonTarry661/message/646771188</stembedurl>Another user sounded optimistic about Innovation Beverage’s value after the merger with BlockFuel Energy is complete.&nbsp;<stembedurl>https://stocktwits.com/grandearthling/message/646771370</stembedurl><h2 class="st-heading-2">Merger Timeline And Strategy</h2>IBG and BlockFuel Energy, whose merger was announced in October, expect to finalize their combination during the first quarter of 2026. The combined&nbsp;company will aim to create a platform capable of generating revenue from hydrocarbon production while also exploring new digital energy initiatives.<blockquote>&nbsp;“We view Bitcoin mining not as speculation, but as energy infrastructure. At its core, our strategy is about converting underutilized natural gas at the site into productive, revenue-generating capacity.”- Daniel Lanskey, CEO, BlockFuel</blockquote>After the deal closes, the company will start trading under the ticker “FUEL.” Lanskey will become both chairman and chief executive of the combined company. Ownership of the new entity will be split, with current IBG shareholders holding about 10% and BlockFuel shareholders the remaining 90%.IBG stock has declined by 66% in the last 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/beyond-meat-cuts-the-meat-in-protein-drink-pivot/cZdhuqbRIES">Beyond Meat Cuts The ‘Meat’ In Protein Drink Pivot — Leaves A Bad Taste For Retail Traders</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

IBG and BlockFuel Energy, whose merger was announced in October, expect to finalize their combination during the first quarter of 2026.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.8499
Prev Close	$0.955
Open	$0.8946
Dividend Yield	0.00%
50-Day Moving Average	$0.9317
Beta	1.40
Avg. Volume	28,587.01
PE Ratio	-0.07

52-Week High	$17.58
52-Week Low	$0.7101
Market Capitalization	$4.03M
EPS (Annual)	-$13.09
Price to Book	-0.45
Revenue Per Employee	$346,530.13

Feed

News

Sentiment

Fundamentals

Info

IBG Fundamentals